BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27498771)

  • 1. [Corrigendum] VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review).
    Taurone S; Galli F; Signore A; Agostinelli E; Dierckx RA; Minni A; Pucci M; Artico M
    Int J Oncol; 2016 Oct; 49(4):1766. PubMed ID: 27498771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corrigendum] Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor.
    Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
    Int J Oncol; 2016 Mar; 48(3):1306. PubMed ID: 26783042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corrigendum] Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1.
    Abdelbaset-Ismail A; Pedziwiatr D; Schneider G; Niklinski J; Charkiewicz R; Moniuszko M; Kucia M; Ratajczak MZ
    Int J Oncol; 2019 Mar; 54(3):1134. PubMed ID: 30628648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corrigendum] Nonsense-mediated mRNA decay factor Upf2 exists in both the nucleoplasm and the cytoplasm.
    Tatsuno T; Nakamura Y; Ma S; Tomosugi N; Ishigaki Y
    Mol Med Rep; 2017 Dec; 16(6):8573. PubMed ID: 28944923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corrigendum] Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis.
    Nogimori K; Hori T; Kawaguchi K; Fukui T; Mii S; Nakada H; Matsumoto Y; Yamauchi Y; Takahashi M; Furukawa K; Tetsuya O; Yokoi K; Hasegawa Y; Furukawa K
    Int J Oncol; 2017 Feb; 50(2):746. PubMed ID: 27959390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corrigendum] Emerging roles of non‑coding RNAs in the response of rectal cancer to radiotherapy (Review).
    Thi HTH; Duong HQ; Hong S
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34278454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corrigendum] Pivotal roles of protein 4.1B/DAL‑1, a FERM‑domain containing protein, in tumor progression (Review).
    Yuan X; Piao L; Wang L; Han X; Zhuang M; Liu Z
    Int J Oncol; 2020 Feb; 56(2):641. PubMed ID: 31814035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
    Moro L; Arbini AA; Marra E; Greco M
    Int J Oncol; 2016 Jun; 48(6):2722. PubMed ID: 27082245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corrigendum] Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.
    Du P; Ye L; Yang Y; Jiang WG
    Int J Oncol; 2018 Apr; 52(4):1364. PubMed ID: 29484375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corrigendum] Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
    Gil EY; Jo UH; Jeong H; Whang YM; Woo OH; Cho KR; Seo JH; Kim A; Lee ES; Koh I; Kim YH; Park KH
    Int J Oncol; 2017 Apr; 50(4):1455. PubMed ID: 28350046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.
    Xu J; Jiang N; Shi H; Zhao S; Yao S; Shen H
    Int J Oncol; 2017 Jun; 50(6):2236. PubMed ID: 28498450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corrigendum] Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells.
    Izutani Y; Yogosawa S; Sowa Y; Sakai T
    Int J Oncol; 2016 Mar; 48(3):1305. PubMed ID: 26718100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.
    Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
    Int J Oncol; 2016 Sep; 49(3):1260. PubMed ID: 27573164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corrigendum] Cancer‑related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction.
    Feng LR; Wolff BS; Liwang J; Regan JM; Alshawi S; Raheem S; Saligan LN
    Int J Mol Med; 2020 Jun; 45(6):1960. PubMed ID: 32186755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corrigendum] Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells.
    Yamamura M; Noguchi K; Nakano Y; Segawa E; Zushi Y; Takaoka K; Kishimoto H; Hashimoto-Tamaoki T; Urade M
    Int J Oncol; 2016 Nov; 49(5):2188. PubMed ID: 27666023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer.
    Kim SL; Min IS; Park YR; Lee ST; Kim SW
    Int J Oncol; 2019 May; 54(5):1897. PubMed ID: 30864690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
    Yamamoto H; Oshiro R; Ohtsuka M; Uemura M; Haraguchi N; Nishimura J; Takemasa I; Mizushima T; Doki Y; Mori M
    Int J Oncol; 2016 Nov; 49(5):2186. PubMed ID: 27634111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corrigendum] Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.
    Suzuki M; Mohamed S; Nakajima T; Kubo R; Tian L; Fujiwara T; Suzuki H; Nagato K; Chiyo M; Motohashi S; Yasufuku K; Iyoda A; Yoshida S; Sekine Y; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I; Fujisawa T
    Int J Oncol; 2015 Aug; 47(2):791. PubMed ID: 26081105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2019 Jun; 54(6):2257. PubMed ID: 30942453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.